Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Reassessing Prospects
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Thursday at a closing price of $9.90, with 4.24 million shares of worth about $41.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.75% during that period and on Thursday the price saw a gain of […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
ARK Investment Management LLC recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 200.36% to 20.65 million shares with purchase of 13.78 million shares. This fresh investment now brings its stake to 9.92% valued currently at $203.65 million. In addition, […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
Recursion Pharmaceuticals Inc (RXRX): Street Finally Waking Up
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
